← Open Payments lookup

AMBER MOBLEY: Open Payments

NPI 1750826798 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,563 in 76 payments from 10 companies in 2025. Trend: 2023 $1,737 · 2024 $1,494 · 2025 $1,563

Food & beverage: $1,491Education: $71
CompanyPaymentsAmount
ABBVIE INC.18$340
Alkermes, Inc.14$317
Teva Pharmaceuticals USA, Inc.11$265
E.R. Squibb & Sons, L.L.C.14$252
Janssen Pharmaceuticals, Inc9$176
Vanda Pharmaceuticals Inc.2$61
Axsome Therapeutics, Inc.3$58
Otsuka America Pharmaceutical, Inc.3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Neurocrine BioSciences, Inc.1$16

Products named: VRAYLAR, ARISTADA, COBENFY, UZEDY, INVEGA SUSTENNA, HETLIOZ, Auvelity, SPRAVATO.

Industry payments across AR — which companies pay providers there.